Journal
CELLULAR AND MOLECULAR LIFE SCIENCES
Volume 78, Issue 2, Pages 469-495Publisher
SPRINGER BASEL AG
DOI: 10.1007/s00018-020-03602-y
Keywords
Pluripotent stem cell; Cell surface marker; Membrane proteins; Proteomics; Mass spectrometry; Regenerative medicine; Single cell proteomics; Cell therapy
Categories
Funding
- Royan Institute
Ask authors/readers for more resources
Stem cells and their derivatives hold promise for tissue replacement therapy, but their heterogeneous characteristics pose challenges. Targeting specific cell surface markers with antibodies has proven efficient in isolating cell populations, with proteomics playing a key role in identifying these markers. Single cell proteomics and surface markers associated with progenitor stages show potential for use in regenerative medicine.
Stem cells and their derivatives are novel pharmaceutics that have the potential for use as tissue replacement therapies. However, the heterogeneous characteristics of stem cell cultures have hindered their biomedical applications. In theory and practice, when cell type-specific or stage-specific cell surface proteins are targeted by unique antibodies, they become highly efficient in detecting and isolating specific cell populations. There is a growing demand to identify reliable and actionable cell surface markers that facilitate purification of particular cell types at specific developmental stages for use in research and clinical applications. The identification of these markers as very important members of plasma membrane proteins, ion channels, transporters, and signaling molecules has directly benefited from proteomics and tools for proteomics-derived data analyses. Here, we review the methodologies that have played a role in the discovery of cell surface markers and introduce cutting edge single cell proteomics as an advanced tool. We also discuss currently available specific cell surface markers for stem cells and their lineages, with emphasis on the nervous system, heart, pancreas, and liver. The remaining gaps that pertain to the discovery of these markers and how single cell proteomics and identification of surface markers associated with the progenitor stages of certain terminally differentiated cells may pave the way for their use in regenerative medicine are also discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available